London - British cyclist Simon Yates failed
a drugs test at the Paris-Nice race in March, with his Australian team
Orica-GreenEdge on Friday blaming an "administrative error" during
treatment for asthma.
The setback comes with British Cycling
already in turmoil over the resignation this week of technical director Shane
Sutton, an Australian, amid allegations he used sexist language and made
derogatory comments, just months from the Rio Olympics.
British Cycling said world governing body
the UCI had informed it of a possible violation and Orica GreenEdge confirmed
the rider was Yates and the substance Terbutaline.
"The substance was given to Simon
Yates in the form of an asthma inhaler and accordingly, this was noted by the
team doctor on the Doping Control Form, signed at the time of the test,"
the team said in a statement.
"The substance was given in an ongoing
treatment of Simon Yates' documented asthma problems."
It said the team doctor made an
administrative error by failing to apply for the therapeutic use exemption
(TUE) required for the use of the treatment.
"The use of Terbutaline without a
current TUE is the reason it has been flagged as an adverse analytical finding.
This is solely based on a human error that the doctor in question has taken
full responsibility for," the team added.
"There has been no wrong-doing on
Simon Yates' part. The team takes full responsibility for this mistake and
wishes to underline their support for Simon during this process."
The UCI did not immediately respond to a
request for comment but Orica said it was submitting all its evidence to
clarify the matter.
The UK Anti-Doping body said its policy was
not to discuss cases until a violation was found to have occurred following a
"UK Anti-Doping does not discuss or
disclose details of any cases until due legal process has been completed and an
anti-doping rule violation is deemed to have been committed," a